9-octadecenamide, N-[2-[2-(8Z-8-heptadecenyl-4,5-dihydro- 1H-imidazol-1-yl]ethyl]-, (9Z-
General Information
| Mainterm | 9-octadecenamide, N-[2-[2-(8Z-8-heptadecenyl-4,5-dihydro- 1H-imidazol-1-yl]ethyl]-, (9Z- |
| CAS Reg.No.(or other ID) | 63441-26-9 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 6437767 |
| IUPAC Name | (Z)-N-[2-[2-[(Z)-heptadec-8-enyl]-4,5-dihydroimidazol-1-yl]ethyl]octadec-9-enamide |
| InChI | InChI=1S/C40H75N3O/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-39-41-35-37-43(39)38-36-42-40(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20H,3-16,21-38H2,1-2H3,(H,42,44)/b19-17-,20-18- |
| InChI Key | VASZKKUIFVKZER-CLFAGFIQSA-N |
| Canonical SMILES | CCCCCCCCC=CCCCCCCCC1=NCCN1CCNC(=O)CCCCCCCC=CCCCCCCCC |
| Molecular Formula | C40H75N3O |
| Wikipedia | 1-(2-oleylamidoethyl)-2-noroleyl-2-imidazoline |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 614.06 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 33 |
| Complexity | 713.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B / I A A A A A A A A A A A A A A A A A A A A Q A A A A A A A A A A A A A A A A A A A A A A H g A Q A A A A C A D B g A Q D A A P A A A C o A C N y N A A A A A E g A A A J C I E 4 A A g A Q B I A i Q A U A A A A l g C I A A M Y i I C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 44.7 |
| Monoisotopic Mass | 613.591 |
| Exact Mass | 613.591 |
| XLogP3 | None |
| XLogP3-AA | 13.7 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 44 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9617 |
| Human Intestinal Absorption | HIA+ | 0.9969 |
| Caco-2 Permeability | Caco2- | 0.5338 |
| P-glycoprotein Substrate | Substrate | 0.7975 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5801 |
| Non-inhibitor | 0.7457 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5849 |
| Distribution | ||
| Subcellular localization | Lysosome | 0.7661 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8331 |
| CYP450 2D6 Substrate | Non-substrate | 0.7265 |
| CYP450 3A4 Substrate | Non-substrate | 0.5000 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8243 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9011 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7647 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8114 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9547 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9772 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8731 |
| Non-inhibitor | 0.8323 | |
| AMES Toxicity | Non AMES toxic | 0.8143 |
| Carcinogens | Non-carcinogens | 0.7957 |
| Fish Toxicity | Low FHMT | 0.8182 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9667 |
| Honey Bee Toxicity | Low HBT | 0.7923 |
| Biodegradation | Not ready biodegradable | 0.9331 |
| Acute Oral Toxicity | III | 0.7256 |
| Carcinogenicity (Three-class) | Non-required | 0.6337 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -1.9516 | LogS |
| Caco-2 Permeability | 0.5832 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.3096 | LD50, mol/kg |
| Fish Toxicity | 1.8326 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.3721 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Organic compounds |
|---|---|
| Superclass | Lipids and lipid-like molecules |
| Class | Fatty Acyls |
| Subclass | Fatty amides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | N-acyl amines |
| Alternative Parents | |
| Molecular Framework | Aliphatic heteromonocyclic compounds |
| Substituents | N-acyl-amine - Imidolactam - 2-imidazoline - Carboxamide group - Secondary carboxylic acid amide - Azacycle - Carboxylic acid amidine - Carboxylic acid derivative - Amidine - Carboximidamide - Propargyl-type 1,3-dipolar organic compound - Organic 1,3-dipolar compound - Organoheterocyclic compound - Organic oxygen compound - Organonitrogen compound - Organooxygen compound - Carbonyl group - Hydrocarbon derivative - Amine - Organic oxide - Organic nitrogen compound - Aliphatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as n-acyl amines. These are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. |
From ClassyFire